All In Biotech

Drug Trial Radar · NCT07272330

A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects

A Phase I Study to Evaluate the Relative Bioavailability of Different HRS-1893 Formulations and the Effect of Food on the Pharmacokinetics of HRS-1893 Tablets in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Apr 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

38

Actual

Start

Dec 11, 2025

Primary completion

Mar 21, 2026

Study completion Mar 21, 2026

Sponsor

Sponsor type
Industry
First posted
Dec 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This Phase I clinical trial will investigate the relative bioavailability between two formulations of HRS-1893 tablets and the influence of food on the drug's pharmacokinetics in healthy adult participants. The safety and tolerability of HRS-1893 will also be monitored.

Conditions

  • Cardiomyopathy

Interventions

  • HRS-1893 tablet ADrug

    Specified dose on specified days.

  • HRS-1893 tablet BDrug

    Specified dose on specified days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Peak concentration (Cmax)Time frame: From Day 1 to Day 25 in part 1, from Day 1 to Day 17 in part 2.
  2. Area under the plasma concentration-time curve from time zero to the last quantifiable time point (AUC0-t)Time frame: From Day 1 to Day 25 in part 1, from Day 1 to Day 17 in part 2.
  3. Area under the plasma concentration-time curve from time zero extrapolated to infinity (AUC0-∞)Time frame: From Day 1 to Day 25 in part 1, from Day 1 to Day 17 in part 2.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beijing Anzhen Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.